[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.249.135. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

January 1, 2017, Vol 2, No. 1, Pages 1-116

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):1. doi:10.1001/jamacardio.2016.3624
Viewpoint

Data Desert for Inferior Vena Caval FiltersLimited Evidence, Supervision, and Research

Abstract Full Text
JAMA Cardiol. 2017;2(1):3-4. doi:10.1001/jamacardio.2016.3764

This Viewpoint argues against inferior vena caval filter use.

A Measured Approach to Vena Cava Filter Use—Respect Rather Than Regret

Abstract Full Text
JAMA Cardiol. 2017;2(1):5-6. doi:10.1001/jamacardio.2016.3882

This Viewpoint argues for inferior vena cava filter use.

From the Heart

The 1% Club

Abstract Full Text
JAMA Cardiol. 2017;2(1):13-14. doi:10.1001/jamacardio.2016.4053
Editorial

Perspective on Trends in Statin Use

Abstract Full Text
JAMA Cardiol. 2017;2(1):11-12. doi:10.1001/jamacardio.2016.4710

Interpretation and Use of Another Statin Guideline

Abstract Full Text
JAMA Cardiol. 2017;2(1):7-9. doi:10.1001/jamacardio.2016.4950

The Democratization of Medical Research and Education Through Social MediaThe Potential and the Peril

Abstract Full Text
JAMA Cardiol. 2017;2(1):9-11. doi:10.1001/jamacardio.2016.4933
Original Investigation

Use of Sex-Specific Clinical and Exercise Risk Scores to Identify Patients at Increased Risk for All-Cause Mortality

Abstract Full Text
JAMA Cardiol. 2017;2(1):15-22. doi:10.1001/jamacardio.2016.3720

This cohort study investigates whether exercise and clinical variables have differential associations with mortality outcomes in men and women and assesses whether sex-specific risk scores better estimate all-cause mortality among patients undergoing treadmill testing.

Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States

Abstract Full Text
JAMA Cardiol. 2017;2(1):25-33. doi:10.1001/jamacardio.2016.4188

This cross-sectional study uses data from the US National Inpatient Sample database to assess the inpatient mortality rate associated with percutaneous coronary intervention in centers without on-site cardiac surgery compared with centers with on-site cardiac surgery.

Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non–ST-Segment Elevation Myocardial Infarction

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(1):36-44. doi:10.1001/jamacardio.2016.3855

This study examines interhospital variation in intensive care unit use in the United States for older adults with hemodynamically stable non–ST-segment myocardial infarction and outcomes associated with intensive care unit use among patients with low, moderate, or high mortality risk.

Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease

Abstract Full Text
JAMA Cardiol. 2017;2(1):47-54. doi:10.1001/jamacardio.2016.4052

This cohort study examines the association between all-cause mortality and intensity of statin therapy in patients with atherosclerotic cardiovascular disease in the Veterans Affairs health care system.

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013Insights From the Medical Expenditure Panel Survey

Abstract Full Text
JAMA Cardiol. 2017;2(1):56-65. doi:10.1001/jamacardio.2016.4700

This cohort study details the trends in use and total and out-of-pocket expenditures associated with statins in a representative US adult population from 2002 to 2013.

Feasibility of Obtaining Measures of Lifestyle From a Smartphone AppThe MyHeart Counts Cardiovascular Health Study

Abstract Full Text
open access
JAMA Cardiol. 2017;2(1):67-76. doi:10.1001/jamacardio.2016.4395

This cardiovascular health study assesses the feasibility of obtaining measures of physical activity, fitness, and sleep from a smartphone app and provides insights into activity patterns associated with life satisfaction and self-reported disease.

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With EnalaprilA Secondary Analysis of the PARADIGM-HF Trial

Abstract Full Text
JAMA Cardiol. 2017;2(1):79-85. doi:10.1001/jamacardio.2016.4733

This secondary analysis of a randomized clinical trial reports on whether the risk of hyperkalemia associated with use of mineralocorticoid receptor antagonists for patients with heart failure and reduced ejection fraction is reduced by sacubitril/valsartan in comparison with enalapril.

Brief Report

A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer

Abstract Full Text
JAMA Cardiol. 2017;2(1):88-93. doi:10.1001/jamacardio.2016.3841

This population-based cohort study uses data from the Ontario Cancer Registry to describe the incidence of cardiovascular death in a contemporary population of women with early-stage breast cancer while accounting for competing risks.

Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy

Abstract Full Text
has multimedia
JAMA Cardiol. 2017;2(1):94-97. doi:10.1001/jamacardio.2016.3894

This case report stresses the importance of considering associated disease processes when patients with stable hypertophic cardiomyopathy experience rapid congestive heart failure.

Invited Commentary

Can We Improve Mortality Estimation in Women After Treadmill Testing by Using Sex-Specific Scores?

Abstract Full Text
JAMA Cardiol. 2017;2(1):22-24. doi:10.1001/jamacardio.2016.3687

Percutaneous Coronary Intervention Without On-site Cardiac SurgeryIt’s Trendy, but Is It Right?

Abstract Full Text
JAMA Cardiol. 2017;2(1):34-35. doi:10.1001/jamacardio.2016.4227

Who Belongs in the Cardiac Intensive Care Unit?

Abstract Full Text
JAMA Cardiol. 2017;2(1):45-46. doi:10.1001/jamacardio.2016.3881

First Steps Into the Brave New Transdiscipline of Mobile Health

Abstract Full Text
JAMA Cardiol. 2017;2(1):76-78. doi:10.1001/jamacardio.2016.4440

Hyperkalemia, Sacubitril/Valsartan, and Mineralocorticoid Antagonists in Patients With Heart Failure

Abstract Full Text
JAMA Cardiol. 2017;2(1):86-87. doi:10.1001/jamacardio.2016.4731
JAMA Cardiology Clinical Challenge

A Woman With Progressive Dyspnea and Fatigue

Abstract Full Text
has multimedia
JAMA Cardiol. 2017;2(1):101-102. doi:10.1001/jamacardio.2016.3689

A woman aged 44 years with no significant medical history presented with increasing exertional dyspnea and fatigue. During coronary angiography, the patient was noted to have diffuse 90% to 95% narrowing of the left main coronary artery at its origin. What would you do next?

JAMA Cardiology Clinical Guidelines Synopsis

Guidelines for Listing Candidates for Heart TransplantA 10-Year Update

Abstract Full Text
JAMA Cardiol. 2017;2(1):98-99. doi:10.1001/jamacardio.2016.3756

This Clinical Guideline Synopsis summarizes an international guideline update of the International Society for Heart Lung Transplantation Listing Criteria for Heart Transplantation.

Research Letter

Accuracy of Wrist-Worn Heart Rate Monitors

Abstract Full Text
JAMA Cardiol. 2017;2(1):104-106. doi:10.1001/jamacardio.2016.3340

This study assesses the accuracy of 4 popular wrist-worn heart rate monitors under conditions of varying physical exertion.

Comment & Response

Refining the Diagnosis of Type 2 Myocardial Infarction

Abstract Full Text
JAMA Cardiol. 2017;2(1):106. doi:10.1001/jamacardio.2016.3698

Refining the Diagnosis of Type 2 Myocardial Infarction

Abstract Full Text
JAMA Cardiol. 2017;2(1):106-107. doi:10.1001/jamacardio.2016.3717

Refining the Diagnosis of Type 2 Myocardial Infarction—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(1):107. doi:10.1001/jamacardio.2016.3701

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men

Abstract Full Text
JAMA Cardiol. 2017;2(1):107-108. doi:10.1001/jamacardio.2016.3714

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(1):108-110. doi:10.1001/jamacardio.2016.3711

Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy

Abstract Full Text
JAMA Cardiol. 2017;2(1):110-111. doi:10.1001/jamacardio.2016.3767

Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(1):111. doi:10.1001/jamacardio.2016.3770
Editor's Note

High-Intensity Statins for Secondary Prevention

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):55. doi:10.1001/jamacardio.2016.4479

Statins—Almost 30 Years of Use in the United States and Still Not Quite There

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):66. doi:10.1001/jamacardio.2016.4709

Making Every Mobile Heart Count!

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):78. doi:10.1001/jamacardio.2016.4638
JAMA Cardiology Patient Page

Prevention of Heart Failure

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):116. doi:10.1001/jamacardio.2016.3394
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(1):2. doi:10.1001/jamacardio.2016.3625
×